Audited Financial Results_March 31, 2025
Results_Audited Financial Results For The Quarter And Year Ended March 31, 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Titan Biotech Limited on 6ix
Earlier from Titan Biotech
- Board Meeting Outcome for Outcome Of Board Meeting
- Titan Biotech Limited Press Release May 26 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Consideration Of Recommendation Of Final Dividend, If Any For The Financial
- Titan Biotech Limited Press Release Mar 25 2025
Later from Titan Biotech
- Appointment Of Secretarial Auditor
- Appointment Of Cost Auditor
- Appointment Of Internal Auditor
- Corporate Action-Board to consider Dividend
- Titan Biotech Limited Press Release May 30 2025
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech